Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Change in Inventory (2021 - 2024)

Goldenwell Biotech filings provide 4 years of Change in Inventory readings, the most recent being $73.0 for Q4 2024.

  • On a quarterly basis, Change in Inventory rose 103.26% to $73.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $83.0, a 104.46% increase, with the full-year FY2024 number at -$75.0, up 93.72% from a year prior.
  • Change in Inventory hit $73.0 in Q4 2024 for Goldenwell Biotech, up from -$69.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $103125.0 in Q1 2021 to a low of -$20663.0 in Q3 2022.
  • Median Change in Inventory over the past 4 years was -$103.5 (2023), compared with a mean of $15692.3.
  • The widest YoY moves for Change in Inventory: up 2607.04% in 2022, down 293.58% in 2022.
  • Goldenwell Biotech's Change in Inventory stood at -$1804.0 in 2021, then skyrocketed by 2607.04% to $45227.0 in 2022, then tumbled by 104.95% to -$2240.0 in 2023, then soared by 103.26% to $73.0 in 2024.
  • The last three reported values for Change in Inventory were $73.0 (Q4 2024), -$69.0 (Q2 2024), and $79.0 (Q1 2024) per Business Quant data.